Fujifilm India Pvt. Ltd. is pleased to announce that Fujifilm Corporation has introduced x-ray solutions augmented with qXR*1, Qure.ai’s computed aided radiology software application designed with deep-learning Artificial Intelligence (AI) technology.
According to Qure.ai, the AI will analyze X-ray images to detect abnormal findings within seconds. In addition, Fujifilm’s portable x-ray FDR Xair system is equipped with a new image processing box called Expansion Unit EX-Mobile*2, enabling it to connect with qXR software. It will assist clinicians and technicians by flagging abnormal findings at the point of care.
Qure’s peer-reviewed and proven chest X-ray interpretation technology, qXR, can detect suspected abnormalities indicative of COVID-19, tuberculosis, lung cancer, misplaced catheters, and multiple other radiological findings allowing for further review and confirmatory testing. The technology has been extensively trained on a global dataset and can be used for both adults and pediatric images.
Fujifilm and Qure partnership will support the expansion of TB screening
Another significant advancement is that the combination of Ex-Mobile with Fujifilm’s portable x-ray FDR Xair system will benefit Qure’s AI technology not only to hospitals but also to regions that are geographically distant from the cities and emergency critical care. Furthermore, it will respond to the rapidly increasing global demand for support for effective lung procedures at medical sites, especially during disease outbreaks.
“Fujifilm and Qure’s technology will deliver a support tool to assist the care providers for accurate diagnosis faster. With the help of Technology and special examination, we can diagnose the disease while it is asymptomatic, with no signs or symptoms. The earlier detection of disease may lead to more cures or longer survival. Our partnership with Qure will support the expansion of Tuberculosis(TB) screening in India and other developing countries where there is limited access to such health services. We believe there’s tremendous potential in this partnership,” said Koji Wada, General Manager, Medical Division, Fujifilm, India.
“We are delighted to partner with Fujifilm to improve quality of care by accelerating patient triage, diagnostics, and treatment. Qure.ai’s CE- certified and WHO endorsed technology will elevate patient care and reduce radiologists’ workload across healthcare institutions,” said Prashant Warier, CEO and Co-Founder, Qure.ai.
Fujifilm customers will be able to select one of the clinical packages available with qXR, including:
· qXR-COVID-19, which helps to monitor changes in lung density.
· qXR-Lung Nodule that enables early detection of metastatic lung cancer by automated pulmonary nodule detection.
· qXR-TB helps reduce the waiting time for confirmatory tests for diseases like Tuberculosis.
· qXR-Critical Care can detect misplaced catheters and tubes commonly used in critical care settings for monitoring body functions and administering medications.
Fujifilm and Qure aim to provide high-quality care in the increasingly dynamic and complex healthcare environment through future-proof AI technology.
*1 Available in select CE Mark countries. Not available in all regions.
*2 Expansion Unit Ex-Mobile is an optional product of Fujifilm’s FDR D-EVO II DR cassette.
